Farms.com Home   News

The high-tech future of meat is just around the corner

Meat producers are paying attention now that a cultured meat company has passed a key regulatory hurdle.

Upside Foods became the first company to receive a “no questions” letter from the U.S. Food and Drug Administration. Despite some headlines, it has not received approval for any products but the FDA said it has no qualms about the Upside Foods cultured chicken manufacturing process.

Cultured meat is not a meat substitute like some of the plant-protein-based products that have recently hit the market. It is made of animal muscle cells grown in a lab.

The process first made headlines in 2013, when a hamburger made from lab-grown animal cells was announced with much fanfare. But with a price tag of more than US$250,000, it wasn’t an option likely to show up on fast-food menus.

Click here to see more...

Trending Video

A new era in biostimulants and bionutritionals

Video: A new era in biostimulants and bionutritionals


In response to the growing need for efficient, effective biosolutions, HGS BioScience continues to expand its footprint in the bionutritional and biostimulant market with the acquisition of NutriAg, Ltd. The Paine Schwartz Partners-backed HGS BioScience is a global leader in humic and fulvic acid products. Toronto-based NutriAg is an innovator in bionutritional technologies with a deep R&D engine. North American growers and retailers will benefit from:

• Solutions across the biostimulant spectrum - including humics, fulvics, bionutritionals, carbohydrate chelation, amino acids, plant and seaweed extracts, and microbial technologies.
• A portfolio and R&D pipeline of science-backed solutions proven to drive crop productivity and farm profitability.
• Actionable nutrient insights and recommendations based on data specific to their farm and cropping goals with the NutriAnalytics platform